Document is current
Any future updates will be listed below
-
Authors
Rajput, Sanjna
Vierkant, Robert A.
Olson, Kayleigh N.
Larson, Nicole L.
Stan, Daniela L.
Mussallem, Dawn M.
D’Andre, Stacy D.
Couch, Fergus J.
Olson, Janet E.
O’Sullivan, Ciara C.
Ruddy, Kathryn J.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R35 CA253187, U24 CA258058 and P50 CA116201)
National Cancer Institute (Grant Number P30 CA015083)
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 1 January 2026
Accepted: 30 March 2026
First Online: 17 April 2026
Declarations
:
: Financial Interests: Dr. Ciara O’Sullivan has received research support paid to their institution by Genentech, Pfizer and Jazz Pharmaceuticals, honoraria from OncLive and Medscape, and consults for Daiichi Sankyo. Dr. Fergus Couch has received research funding from GRAIL and consults for AstraZeneca. Non-financial interest: Dr. Ciara O’Sullivan is a member of steering committees at AstraZeneca and Pfizer.
: This is an observational study. The Mayo Clinic Institutional Review Board has confirmed that no ethical approval is required.
: Informed consent was obtained from all individual participants included in the study.
